Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
5.26
+0.05 (1.02%)
May 6, 2026, 1:49 PM EDT - Market open
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $13.36 million as of May 6, 2026. Its market cap has decreased by -54.63% in one year.
Market Cap
13.36M
Enterprise Value
1.42M
1-Year Change
-54.63%
Ranking
Category
Stock Price
$5.26
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $13.36M, a decrease of -79.76%. That is a compound annual growth rate of -42.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 13.23M | -46.31% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jupiter Neurosciences | 13.94M |
| Hoth Therapeutics | 13.75M |
| Lunai Bioworks | 13.47M |
| Psyence Biomedical | 13.42M |
| Cyclerion Therapeutics | 13.35M |
| Moleculin Biotech | 13.34M |
| Phio Pharmaceuticals | 13.13M |
| BioVie | 13.01M |